Palvella Therapeutics (PVLA) Shareholder's Equity Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 318.00% |
| Dec 31, 2025 | -55.30% |
| Sep 30, 2025 | 144.26% |
| Jun 30, 2025 | 159.11% |
| Mar 31, 2025 | 172.30% |
| Dec 31, 2024 | 184.06% |
| Sep 30, 2024 | -386.48% |
| Jun 30, 2024 | -299.59% |
| Mar 31, 2024 | -597.30% |
| Dec 31, 2023 | 20.57% |
| Jun 30, 2023 | -8.72% |
| Mar 31, 2023 | -71.08% |
| Dec 31, 2022 | -284.76% |
| Jun 30, 2022 | -5.04% |
| Mar 31, 2022 | 39.79% |
| Dec 31, 2021 | 63.58% |
| Sep 30, 2021 | 23.26% |
| Jun 30, 2021 | 0.10% |
| Mar 31, 2021 | -23.23% |
| Dec 31, 2020 | -39.58% |
| Sep 30, 2020 | 111.66% |
| Jun 30, 2020 | 139.53% |
| Mar 31, 2020 | 65.13% |
| Dec 31, 2019 | 28.59% |
| Sep 30, 2019 | -58.93% |
| Jun 30, 2019 | -64.77% |
| Mar 31, 2019 | -40.50% |
| Dec 31, 2018 | 246.60% |
| Sep 30, 2018 | 1,002.65% |
| Jun 30, 2018 | 492.63% |
| Mar 31, 2018 | 181.06% |
| Dec 31, 2017 | -54.33% |
| Sep 30, 2017 | -85.52% |
| Jun 30, 2017 | -74.97% |
| Mar 31, 2017 | -33.63% |
| Dec 31, 2016 | -18.96% |
| Sep 30, 2016 | -6.44% |
| Jun 30, 2016 | 234.54% |
| Mar 31, 2016 | 91.01% |
| Dec 31, 2015 | 72.87% |
| Sep 30, 2015 | 3,722,530.86% |
| Jun 30, 2015 | 111,216.12% |
| Mar 31, 2015 | 297,867.96% |
| Dec 31, 2014 | 2,977.98% |
| Jun 30, 2014 | 111.89% |